Team

Stéphanie Dupont, PhD

Chief Executive Officer

Dr. Stéphanie Dupont brings extensive experience in Life Sciences and MedTech, combining scientific expertise with strategic business leadership. She has held senior roles at Barco, miDiagnostics, Talis Biomedical, and HP, leading global product development and commercialization. She holds a Ph.D. in Materials Science and Engineering from Stanford University and previously worked as a management consultant at Bain & Company. 

Els Hubloux

Chief Financial Officer

Prior to joining 4Tissue as CFO, Els was a Partner at Newton Biocapital Partners. She has over 28 years of experience in the life sciences sector, of which 22 years as a venture capital professional. She has been a director of various life sciences and medtech companies. Els holds a Master's degree in chemical engineering.  

Lana Van Damme, MD, PhD

CSO & Co-founder

Lana Van Damme received her medical degree from the University of Ghent, where she started her residency in the Department of Plastic and Reconstructive Surgery in 2023. In 2018, she obtained an FWO SB mandate for an interdisciplinary PhD project between the faculty of Sciences of Ghent University in the Polymer Chemistry & Biomaterials Research group (PBM) and the Department of Plastic and Reconstructive Surgery. She has published 3 Q1 articles, as well as co-authored 2 Q1 articles, in the first 2 years.

Vesna Kostanjevecki, PhD

Head of Clinical and Regulatory Affairs

Dr. Vesna Kostanjevecki brings extensive experience in clinical and regulatory affairs, with a strong background in R&D and molecular biology. Before joining 4Tissue, she held senior leadership roles at miDiagnostics, imec, and Fujirebio Europe. She holds a Ph.D. in Biochemistry from Ghent University and a Master's degree in Engineering from the University of Zagreb.

Katleen Verleysen, PhD

Independent Chair

Phillip Blondeel, MD, PhD

Clinical Expert & Co-founder

Virginie Saverys

Board member

Nicolas De Reuck

Board member